跳到正文
原文
Endpoints News 生物医药· Nicole DeFeudis·· 2026-10-01AI 评分33

患者死亡引发 Bristol Myers Squibb 肺病候选药物安全性疑虑

Patient death raises liver questions ahead of Bristol Myers readout

AI 导读

Bristol Myers Squibb 公布的肺病候选药物出现一例患者死亡病例,引发安全性问题。该事件发生在公司即将发布相关数据读出之前。

正文

A pa­tient’s death is rais­ing safe­ty ques­tions ahead of an up­com­ing read­out for Bris­tol My­ers Squibb’s lung dis­ease can­di­date.

Bris­tol My­ers dis­closed one case of …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

来源:Endpoints News 生物医药 · endpoints.news